WHITEHAWK THERAPEUTICS, INC. Additional Paid in Capital, Common Stock
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Additional Paid in Capital, Common Stock of $575.07 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-06
- 2026-06-30: Additional Paid in Capital, Common Stock $575.07M.
- 2026-03-31: Additional Paid in Capital, Common Stock $491.63M.
- 2025-12-31: Additional Paid in Capital, Common Stock $489.44M.
- 2025-09-30: Additional Paid in Capital, Common Stock $487.02M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $575.07M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $491.63M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $489.44M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $487.02M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $484.31M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $481.36M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $385.11M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $383.21M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $380.65M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $377.72M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $374.13M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $370.90M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $367.85M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $364.44M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $361.69M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $358.49M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $283.54M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $281.17M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $279.09M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $277.62M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $190.61M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $190.02M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $20.16M 10-K · filed 2022-03-17 | $189.60M 10-K · filed 2021-03-11 |
| 2020-09-30 | $189.15M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $179.47M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $179.16M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $178.77M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $179.50M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $178.85M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $178.25M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $177.62M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $176.95M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $169.88M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $127.10M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $126.00M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $125.74M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $125.61M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $125.47M 10-Q · filed 2017-05-15 | |
| 2013-03-31 | $49.50K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $49.50K 10-Q · filed 2013-05-15 | |
| 2012-09-30 | $49.50K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $49.50K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $49.50K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $49.50K 10-K · filed 2013-03-28 | |
| 2011-09-30 | $49.50K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $49.50K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $49.50K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |